Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance

Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance

Background To evaluate the safety and effectiveness of empagliflozin in routine clinical settings, we collected and assessed the clinical profiles of Korean patients with type 2 diabetes mellitus. Methods This was a post-marketing surveillance study of empagliflozin 10 and 25 mg. Information on adve...

Full description

Bibliographic Details
Main Authors: Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won
Format: Article
Language:English
Published: Korean Diabetes Association 2023-01-01
Series:Diabetes & Metabolism Journal
Subjects:
diabetes mellitus, type 2
empagliflozin
hypoglycemic agents
product surveillance, postmarketing
sodium-glucose transporter 2 inhibitors
Online Access:http://www.e-dmj.org/upload/pdf/dmj-2021-0356.pdf

Internet

http://www.e-dmj.org/upload/pdf/dmj-2021-0356.pdf

Similar Items